• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconRoche

Roche

0
HealthAC Immune shares surge on Alzheimer’s drug trial results
By Naomi Kresge, James Paton and BloombergAugust 31, 2021
HealthCOVID proves to be double-edged sword for Swiss healthcare giant Roche
By Christiaan Hetzner and Christiaan HetznerJuly 22, 2021
HealthHospitals are charging hundreds per COVID test. Will insurance premiums rise to compensate?
By Hannah Norman and Jay Hancock, Kaiser Health NewsMay 7, 2021
HealthMeet the most innovative and inventive pharmaceutical companies of 2021
By Sy Mukherjee and IDEA PharmaApril 16, 2021
NewslettersBond yields retreat, sending Nasdaq futures higher and Bitcoin lower
By Bernhard WarnerMarch 15, 2021
Roche logo
TechRoche to use quantum computing for drug discovery
By Jeremy KahnJanuary 28, 2021
MagazineWhat the World’s 25 Best Workplaces have in common
By Brett HaenselOctober 19, 2020
SWITZERLAND-ECONOMY-PHARMA-ROCHE
NewslettersRoche tried to see if its arthritis drug could fight coronavirus. It didn’t work
By Sy MukherjeeJuly 29, 2020
HealthRoche says demand for COVID-19 tests exceeds production
By BloombergJune 27, 2020
Health5 companies to keep an eye on following the world’s largest cancer conference
By Sy MukherjeeJune 3, 2020
Roche antibody test Elecsys
NewslettersAntibody testing’s chicken and egg problem
By Sy MukherjeeMay 14, 2020
HealthAntibody testing will be key—once we understand what the results mean
By Sy MukherjeeMay 12, 2020
HealthHow Roche’s new coronavirus test sped its way to FDA authorization
By Sy MukherjeeMarch 13, 2020
Medical personnel collect a sample from a patient at a drive-thru COVID-19 testing clinic at a Kaiser Permanente facility in San Francisco on March 12, 2020.
HealthU.S. gives ’emergency’ authorization to new Roche coronavirus test that’s 10 times faster
By Tim Loh and BloombergMarch 13, 2020
Sarepta Stock Roche Deal
HealthControversial Biotech Sarepta Keeps Up Unlikely Win Streak With $1.15 Billion Roche Deal
By Sy MukherjeeDecember 23, 2019
0
Most Popular
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strongAn image of a popular article
By Fortune EditorsMarch 24, 2026
Commentary
The Treasury just declared the U.S. insolvent. The media missed itAn image of a popular article
By Fortune EditorsMarch 23, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers — ‘or you’re neurodivergent’An image of a popular article
By Fortune EditorsMarch 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.